Preliminary Phase 2 Data Shows Psilocybin for PTSD Is Well-Tolerated

Initial data from phase 2 safety profile for psilocybin in the treatment of PTSD indicates the treatment is well-tolerated.

Related Keywords

New York ,United States ,Maryland ,United Kingdom ,London ,City Of ,Rockville ,James Rucker ,Guy Goodwin ,Institute Of Psychiatry ,Psychoactive Trials Group At King College ,Icahn School Of Medicine At Mount Sinai ,King College ,Icahn School ,Mount Sinai ,New York City ,Sunstone Therapies ,Compass Pathways ,Psychoactive Trials Group ,